micky
Lv1
50 积分
2024-03-07 加入
-
The antibody–drug conjugate landscape
11天前
已完结
-
Zolbetuximab plus mFOLFOX6 in patients with CLDN18.2-positive, HER2-negative, untreated, locally advanced unresectable or metastatic gastric or gastro-oesophageal junction adenocarcinoma (SPOTLIGHT): a multicentre, randomised, double-blind, phase 3 trial
1个月前
已完结
-
CD19 CAR T-Cell Therapy in Autoimmune Disease — A Case Series with Follow-up
1个月前
已完结
-
Golidocitinib, a selective JAK1 tyrosine-kinase inhibitor, in patients with refractory or relapsed peripheral T-cell lymphoma (JACKPOT8 Part B): a single-arm, multinational, phase 2 study
1个月前
已完结
-
CD98 signals controlling tumorigenesis
1个月前
已完结
-
Exploring the next generation of antibody–drug conjugates
1个月前
已完结
-
A Phase I Study of IGN523, a Novel Anti-CD98 Monoclonal Antibody in Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML)
1个月前
已关闭